Copper Peptides: A Research Review of the GHK-Cu Family, AHK-Cu, GHK Basic and the ATCUN Copper-Binding Motif

By Peptide Insider Research Team · 12 min read · Last updated 10 September 2026

Copper peptides are short amino-acid sequences that bind Cu(II) through an N-terminal histidine-containing motif, the best-characterised being the copper tripeptide glycyl-L-histidyl-L-lysine:Cu(II) (GHK-Cu, INCI name copper tripeptide-1) first isolated from human plasma albumin fractions in 1973 [1,2]. This review treats the copper-peptide family as a class rather than a single compound: it describes the coordination chemistry that distinguishes a copper peptide from its metal-free parent, compares GHK-Cu with the related alanyl-histidyl-lysine complex AHK-Cu and with the broader ATCUN (amino-terminal Cu- and Ni-binding) motif, summarises the preclinical evidence by research domain, and reconciles the many catalogue and search labels — ghk-cu peptides, peptides copper, cooper peptides, ghkc and others — under which the same molecules circulate. Peptide Insider's separate GHK-Cu compound review covers the single tripeptide in depth; this article addresses the family and its nomenclature. All content is provided strictly for research reference.

Introduction

The question what is ghk cu peptide, and its hyphenated twin what is ghk-cu peptide, is among the most common search formulations in this niche, yet the answer depends on which of two chemically distinct species is meant. GHK (Gly-His-Lys) is a tripeptide; GHK-Cu is a 1:1 coordination complex in which a Cu(II) ion is chelated by the peptide's N-terminal amine, a deprotonated backbone amide nitrogen and the imidazole nitrogen of histidine [6]. Several biological readouts that are routinely attributed to "GHK" in vendor literature were in fact generated with the copper complex, and in at least one well-controlled fibroblast system the effect was reproduced by copper ions alone but not by metal-free GHK [7]. Distinguishing the two forms determines which study a researcher can legitimately cite.

The class has an unusual research history. Pickart and Thaler identified the tripeptide in 1973 as a factor in human serum that prolonged the survival of cultured normal hepatocytes while stimulating growth of neoplastic liver cells [1], and confirmed the activity with a synthetic tripeptide the same year [8]. Structural work in the 1980s defined the copper complex [6], fibroblast studies in the 1980s and 2000s established matrix effects [7,9,10], and a Connectivity Map analysis in 2012 identified GHK as a compound whose transcriptional signature reverses an emphysema-associated gene expression pattern [11]. Two long reviews by Pickart and colleagues collect this literature [2,3,12], and the 2018 review in particular is the source of the frequently repeated claim that GHK modulates the expression of a large fraction of human genes [2].

Biological background: copper coordination as the defining feature

Copper is an essential trace metal handled in plasma largely by ceruloplasmin and albumin. Human serum albumin binds Cu(II) at its N-terminus (Asp-Ala-His), the prototype of what Harford and Sarkar formalised as the ATCUN motif: a free N-terminal amine, any two residues, and a histidine at position 3 [5]. GHK fits a closely related pattern — His at position 2 rather than 3 — and forms a stable mononuclear complex in which copper is equatorially coordinated by two or three nitrogen donors at neutral pH, as shown by NMR and EPR spectroscopy [6]. Because the tripeptide's copper affinity is comparable to that of albumin's binding site, GHK has been proposed to participate in copper exchange between albumin and cells, although the physiological significance of this exchange remains a hypothesis rather than a demonstrated mechanism [3,12].

Plasma GHK concentration has been reported to fall with age, from roughly 200 ng/mL at age 20 to about 80 ng/mL at age 60, a decline that Pickart and Margolina relate to reduced tissue repair capacity [2,3]. This observation is correlational and derived from small sample sets; it has not been independently replicated in a modern cohort, and the review authors themselves present it as a rationale for further work rather than as an established mechanism.

The same authors have proposed that GHK's release from parent proteins (it occurs as a sequence within collagen α2(I), SPARC/osteonectin and other matrix proteins) may act as a signal of tissue injury [3]. Direct in vivo measurement of GHK liberation during wound repair has not been reported.

Structure and mechanism of action

GHK versus GHK-Cu: what the copper adds

Structurally, GHK-Cu is a small, water-soluble complex with a molecular mass of roughly 403 Da for the copper-bound form (340 Da for the free tripeptide). Freedman and colleagues established the 1:1 stoichiometry and nitrogen-rich coordination sphere in solution [6]; Conato and colleagues later compared GHK with two analogues in which histidine was replaced by synthetic residues, showing that the imidazole nitrogen is central to both copper binding strength and biological activity in their cell assays [4]. Metal-free GHK is catalogued as "GHK basic" precisely because it lacks this complex.

Functionally, the copper appears to matter for some readouts but not for others. In fibroblast culture, Maquart and colleagues reported that GHK-Cu stimulated collagen synthesis at nanomolar concentrations [9], and Siméon and colleagues subsequently found that GHK-Cu increased matrix metalloproteinase-2 (MMP-2) expression — an effect reproduced by copper ions alone but not by apo-GHK, indicating that the metal, delivered by the peptide, drove the MMP-2 response [7]. By contrast, Gruchlik and colleagues observed that GHK, GHK-Cu and CuCl₂ all reduced IGF-2-induced TGF-β1 secretion in normal human dermal fibroblasts, suggesting that here the two forms converge [13]. In the Connectivity Map work, the transcriptional signature was obtained with the tripeptide as profiled in the Broad Institute dataset, and the emphysema-fibroblast rescue used GHK without stated copper supplementation [11].

AHK-Cu and other members of the family

AHK-Cu (L-alanyl-L-histidyl-L-lysine:Cu) substitutes alanine for the N-terminal glycine. Pyo and colleagues studied it in human hair-follicle organ culture and dermal papilla cells, reporting concentration-dependent follicle elongation and dermal papilla cell proliferation over a picomolar-to-nanomolar window, with inhibition at higher concentrations, alongside reduced caspase-3 and PARP cleavage and an increased Bcl-2/Bax ratio [14]. GGH-Cu (glycyl-glycyl-histidine, a canonical ATCUN sequence) has been used chiefly as a chemical model for albumin's binding site [5]. These molecules are grouped as copper peptides because they share coordination chemistry, not interchangeable biological data; AHK-Cu has a much thinner literature than GHK-Cu.

Proposed downstream pathways

Across the preclinical literature, the pathways most consistently associated with GHK-Cu are: increased synthesis of collagen and glycosaminoglycans in fibroblasts [9]; modulation of matrix turnover through MMP-2 and the tissue inhibitors TIMP-1 and TIMP-2 [7]; elevated basic FGF and VEGF secretion, including in irradiated fibroblasts [10]; suppression of NF-κB p65 and p38 MAPK signalling with reduced TNF-α and IL-6 in macrophages [15]; and a TGF-β-like transcriptional programme with actin reorganisation and integrin β1 expression in lung fibroblasts [11]. Antioxidant effects — increased superoxide dismutase activity and suppression of iron release from ferritin — are described in the reviews [2,12] but rest largely on older data sets.

Nomenclature and catalogue variants

Because the family entered research catalogues under an INCI name (copper tripeptide-1), a chemical shorthand (GHK-Cu), and a plain-language class label (copper peptides), and because the shorthand is easily mistyped, the same molecules appear under many strings. The table reconciles the variants most often encountered in supplier listings and search data.

Catalogue or search variant	Refers to	Note
copper peptides · copper peptide · peptides copper	The class (GHK-Cu, AHK-Cu, GGH-Cu and analogues)	Plural usually means the class; singular usually means GHK-Cu specifically
copper tripeptide · copper tripeptide-1	GHK-Cu	INCI designation; "tripeptide" distinguishes it from longer copper-binding sequences
ghk-cu · ghk cu · peptide ghk cu · ghk-cu peptides	GHK-Cu (Gly-His-Lys:Cu(II))	Hyphen, space and word-order variants of the same complex
ghk basic	Metal-free GHK (Gly-His-Lys)	Catalogue term for the apo-tripeptide; not a copper peptide until complexed
ghkc	GHK-Cu	Truncated shorthand dropping the "u"
gkkcu · ghpcu · chk cu	GHK-Cu	Keyboard mis-strikes (K for H, P for K, C for G); none corresponds to a distinct sequence
cooper peptides	Copper peptides	Common misspelling of "copper"; unrelated to any person or brand
AHK-Cu · copper tripeptide-3	Ala-His-Lys:Cu(II)	Distinct compound with its own, smaller literature [14]
GGH-Cu	Gly-Gly-His:Cu(II)	ATCUN model peptide used in coordination chemistry [5]

For research purposes the reliable identifier is the sequence and the presence or absence of copper on the certificate of analysis, together with the copper content (typically stated as a percentage by mass for GHK-Cu lots).

Evidence by research domain

Domain	Model	Principal observation	Form studied	Refs
Extracellular matrix	Human fibroblast culture	Increased collagen synthesis; MMP-2 and TIMP modulation	GHK-Cu	[7,9]
Growth factors	Normal and irradiated fibroblasts	Faster population doubling; higher bFGF and VEGF	GHK-Cu	[10]
Transcriptomics	COPD lung tissue; lung fibroblasts	Reversal of emphysema gene signature; restored collagen contraction	GHK	[11]
Inflammation	RAW 264.7 macrophages; LPS mouse ALI	Reduced ROS, TNF-α, IL-6; NF-κB/p38 suppression; less infiltration	GHK-Cu	[15]
Wound models	Murine scald wound	Faster closure with liposomal GHK-Cu; angiogenesis, VEGF	GHK-Cu liposomes	[16]
Hair follicle biology	Human follicle organ culture; dermal papilla cells	Follicle elongation; anti-apoptotic shift	AHK-Cu	[14]
Fibrosis signalling	Dermal fibroblasts	Reduced IGF-2-driven TGF-β1 secretion	GHK and GHK-Cu	[13]

Matrix and fibroblast studies

The 1988 FEBS Letters report by Maquart and colleagues is the foundational matrix study: GHK-Cu stimulated collagen synthesis in fibroblast cultures at low concentrations [9]. Siméon and colleagues extended this to matrix turnover, showing increased MMP-2 expression and altered TIMP-1/TIMP-2 balance, and made the important control observation that copper alone reproduced the MMP-2 effect while apo-GHK did not [7]. Pollard and colleagues, working with primary fibroblast lines from previously irradiated head-and-neck tissue, reported that 1 nM GHK-Cu accelerated population doubling toward that of non-irradiated controls and increased early bFGF and VEGF output [10].

Transcriptomic and lung research

Campbell and colleagues profiled 64 lung tissue samples from severe COPD and donor lungs, identified 127 genes associated with regional emphysema severity, and queried the Connectivity Map for compounds whose signatures opposed this pattern. GHK emerged as one such compound; in follow-up experiments it recapitulated TGF-β-like gene expression, organised the actin cytoskeleton, increased integrin β1 and restored collagen contraction in fibroblasts from COPD lungs [11]. Separately, Park and colleagues reported that GHK-Cu reduced reactive oxygen species and pro-inflammatory cytokines in macrophages and attenuated LPS-induced acute lung injury in mice through suppression of NF-κB p65 and p38 MAPK [15].

Wound and hair-follicle models

Wang and colleagues encapsulated GHK-Cu in liposomes and reported accelerated scald-wound closure in mice with greater granulation tissue, collagen deposition, vascular density and VEGF expression than controls [16]. The AHK-Cu follicle data of Pyo and colleagues [14] are the principal experimental basis for grouping AHK-Cu with GHK-Cu, though they were obtained ex vivo and in vitro only.

Limitations and research considerations

• Form ambiguity. Many secondary sources cite GHK-Cu data in support of GHK, or vice versa. At least one controlled comparison shows divergent effects of the two forms [7]; researchers should record which species was used.
• Review dependence. A large share of the widely quoted claims — the fraction of the genome modulated, the age-related plasma decline, antioxidant actions — originate in reviews by the peptide's discoverer [2,3,12] and derive from Connectivity Map inference or small early data sets rather than from independent replication.
• Concentration windows. Effects are frequently biphasic: AHK-Cu stimulated follicles at 10^-12–10^-9 M and inhibited at 10^-8–10^-7 M [14]. Concentration-dependent reversals complicate extrapolation between assays.
• Copper toxicity confound. Because free Cu(II) is redox-active, cellular effects of a copper peptide must be separated from those of copper released from the complex, which requires apo-peptide and copper-salt controls not always present in the literature.
• Species and model scope. The in vivo data are murine [15,16]; the human data are in vitro or ex vivo. No controlled human study of a copper peptide as a research compound is discussed here, and none of the preclinical findings establishes any effect in people.
• Handling. GHK-Cu solutions are characteristically blue-violet; loss of colour or precipitation on storage may indicate copper dissociation or oxidation, and lot copper content should be verified analytically.

Where to source for research

GHK-Cu and metal-free GHK are available as lyophilised research-grade material; AHK-Cu is catalogued less widely. Laboratories comparing suppliers typically look for a lot-specific certificate of analysis stating HPLC purity, mass-spectrometry identity, and — for the copper complex — copper content, along with unambiguous labelling of "GHK-Cu" versus "GHK basic" and research-use-only terms. Catalogue listings for copper peptides can be found at Short Chain Aminos, BioPep, Catalyst Research and Apex Research Services. Peptide Insider's supplier evaluation guide and suppliers directory outline the documentation researchers generally request before purchase.

Frequently asked research questions

What is ghk cu peptide?

GHK-Cu is the 1:1 copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, first isolated from human plasma in 1973. Copper is chelated by the N-terminal amine, a backbone amide nitrogen and the histidine imidazole. It is studied in fibroblast, macrophage and murine wound models for matrix, growth-factor and inflammatory-signalling effects [1,6,9,15].

What is ghk peptide without copper?

Metal-free GHK, catalogued as "GHK basic", is the same tripeptide without a coordinated copper ion. Some readouts, such as the emphysema gene-signature reversal, were obtained with GHK itself [11]; others, such as MMP-2 induction, required copper and were not reproduced by the apo-peptide [7]. The two forms are not interchangeable in citations.

Are copper peptides one compound or a class?

A class. "Copper peptides" covers any peptide–Cu(II) complex, most often GHK-Cu but also AHK-Cu (Ala-His-Lys:Cu) and model ATCUN sequences such as GGH-Cu. They share coordination chemistry rather than an evidence base; GHK-Cu has by far the largest literature, AHK-Cu a small ex vivo one [4,5,14].

What do gkkcu, ghpcu, ghkc and chk cu refer to?

All are typographic variants of GHK-Cu produced by adjacent-key errors or dropped letters. None denotes a distinct peptide sequence. When such strings appear in catalogues, the certificate of analysis — sequence, mass and copper content — identifies the material; "cooper peptides" is likewise a misspelling of copper peptides.

Does the copper matter for the reported effects?

For some. Siméon and colleagues found MMP-2 induction was reproduced by copper ions but not by apo-GHK [7], whereas Gruchlik and colleagues found GHK, GHK-Cu and CuCl₂ all lowered IGF-2-driven TGF-β1 secretion [13]. Copper-salt and apo-peptide controls are therefore necessary to attribute an effect to the complex.

How does AHK-Cu differ from GHK-Cu?

AHK-Cu replaces the N-terminal glycine with alanine, preserving the His-Lys copper-binding core. Its published data come from human hair-follicle organ culture and dermal papilla cells, where it produced concentration-dependent follicle elongation and anti-apoptotic marker shifts [14]. No study has compared the two complexes head to head in the same system.

What is the evidence quality across the family?

Mechanistic in vitro data on GHK-Cu are replicated across several laboratories since 1988 [7,9,10,13]. In vivo evidence is limited to mouse models [15,16], and many broad claims trace to reviews by the discoverer [2,3,12]. No controlled human research-compound study is available, and no finding here establishes any effect in people.

Works Cited

1. Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-87. PMID: 4349963.
2. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987. PMID: 29986520.
3. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. doi:10.1155/2015/648108. PMID: 26236730.
4. Conato C, Gavioli R, Guerrini R, et al. Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity. Biochim Biophys Acta. 2001;1526(2):199-210. PMID: 11325542.
5. Harford C, Sarkar B. Amino terminal Cu(II)- and Ni(II)-binding (ATCUN) motif of proteins and peptides: metal binding, DNA cleavage, and other properties. Acc Chem Res. 1997;30(3):123-130. doi:10.1021/ar9501535.
6. Freedman JH, Pickart L, Weinstein B, Mims WB, Peisach J. Structure of the glycyl-L-histidyl-L-lysine-copper(II) complex in solution. Biochemistry. 1982;21(19):4540-4544. doi:10.1021/bi00262a004.
7. Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67(18):2257-2265. PMID: 11045606.
8. Pickart L, Thayer L, Thaler MM. A synthetic tripeptide which increases survival of normal liver cells, and stimulates growth in hepatoma cells. Biochem Biophys Res Commun. 1973;54(2):562-566. PMID: 4356974.
9. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346. PMID: 3169264.
10. Pollard JD, Quan S, Kang T, Koch RJ. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Arch Facial Plast Surg. 2005;7(1):27-31. PMID: 15655171.
11. Campbell JD, McDonough JE, Zeskind JE, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012;4(8):67. doi:10.1186/gm367. PMID: 22937864.
12. Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832. PMID: 22666519.
13. Gruchlik A, Chodurek E, Dzierzewicz Z. Effect of Gly-His-Lys and its copper complex on TGF-β secretion in normal human dermal fibroblasts. Acta Pol Pharm. 2014;71(6):954-958. PMID: 25745767.
14. Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-839. PMID: 17703734.
15. Park JR, Lee H, Kim SI, Yang SR. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget. 2016;7(36):58405-58417. doi:10.18632/oncotarget.11168. PMID: 27517151.
16. Wang X, Liu B, Xu Q, et al. GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis. Wound Repair Regen. 2017;25(2):270-278. doi:10.1111/wrr.12520. PMID: 28370978.

Research Use Only. This article summarises published preclinical and biochemical literature on copper peptides for research reference. It is not medical, cosmetic or veterinary advice; the compounds discussed are not approved for human or veterinary use, and nothing here should be read as a claim of efficacy or safety in people or animals. All content strictly for research reference.

Related reviews: GHK-Cu copper tripeptide · KLOW blend (GHK-Cu, BPC-157, TB-500, KPV) · BPC-157 · TB-500